Nissay Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.44M | Buy |
28,825
+29
| +0.1% | +$9.53K | 0.04% | 244 |
|
|
2025
Q4 | $10.1M | Buy |
28,796
+290
| +1% | +$98K | 0.05% | 218 |
|
|
2025
Q3 | $9.21M | Buy |
28,506
+215
| +0.8% | +$66.9K | 0.05% | 224 |
|
|
2025
Q2 | $11M | Sell |
28,291
-555
| -2% | -$223K | 0.06% | 206 |
|
|
2025
Q1 | $12.5M | Buy |
28,846
+356
| +1% | +$143K | 0.08% | 178 |
|
|
2024
Q4 | $10.6M | Sell |
28,490
-21
| -0.1% | -$8.79K | 0.06% | 199 |
|
|
2024
Q3 | $14.8M | Buy |
28,511
+193
| +0.7% | +$103K | 0.09% | 149 |
|
|
2024
Q2 | $15.3M | Buy |
28,318
+470
| +2% | +$248K | 0.1% | 134 |
|
|
2024
Q1 | $14.4M | Buy |
27,848
+434
| +2% | +$216K | 0.1% | 135 |
|
|
2023
Q4 | $12.9M | Buy |
27,414
+253
| +0.9% | +$117K | 0.1% | 131 |
|
|
2023
Q3 | $11.8M | Buy |
27,161
+878
| +3% | +$398K | 0.1% | 126 |
|
|
2023
Q2 | $11.7M | Sell |
26,283
-961
| -4% | -$443K | 0.1% | 126 |
|
|
2023
Q1 | $12.5M | Sell |
27,244
-1,049
| -4% | -$499K | 0.11% | 118 |
|
|
2022
Q4 | $14.5M | Sell |
28,293
-694
| -2% | -$352K | 0.14% | 109 |
|
|
2022
Q3 | $13.2M | Buy |
28,987
+933
| +3% | +$446K | 0.14% | 104 |
|
|
2022
Q2 | $13.5M | Buy |
28,054
+753
| +3% | +$373K | 0.13% | 99 |
|
|
2022
Q1 | $13.4M | Buy |
27,301
+485
| +2% | +$222K | 0.12% | 113 |
|
|
2021
Q4 | $12.4M | Buy |
26,816
+589
| +2% | +$248K | 0.1% | 130 |
|
|
2021
Q3 | $9.78M | Buy |
26,227
+987
| +4% | +$375K | 0.08% | 142 |
|
|
2021
Q2 | $9.64M | Buy |
25,240
+450
| +2% | +$172K | 0.08% | 145 |
|
|
2021
Q1 | $8.9M | Sell |
24,790
-866
| -3% | -$278K | 0.09% | 144 |
|
|
2020
Q4 | $8.24M | Sell |
25,656
-189
| -0.7% | -$58K | 0.12% | 143 |
|
|
2020
Q3 | $6.94M | Sell |
25,845
-4,324
| -14% | -$1.16M | 0.12% | 139 |
|
|
2020
Q2 | $7.93M | Buy |
30,169
+752
| +3% | +$201K | 0.15% | 140 |
|
|
2020
Q1 | $6.68M | Buy |
29,417
+1,364
| +5% | +$372K | 0.17% | 136 |
|
|
2019
Q4 | $8.47M | Sell |
28,053
-2,212
| -7% | -$609K | 0.19% | 129 |
|
|
2019
Q3 | $7.27M | Buy |
30,265
+1,172
| +4% | +$321K | 0.18% | 138 |
|
|
2019
Q2 | $8.21M | Sell |
29,093
-2,507
| -8% | -$685K | 0.21% | 117 |
|
|
2019
Q1 | $9.07M | Sell |
31,600
-1,521
| -5% | -$440K | 0.24% | 102 |
|
|
2018
Q4 | $8.7M | Sell |
33,121
-308
| -0.9% | -$84.7K | 0.27% | 87 |
|
|
2018
Q3 | $9.16M | Buy |
33,429
+565
| +2% | +$147K | 0.25% | 98 |
|
|
2018
Q2 | $7.82M | Sell |
32,864
-963
| -3% | -$223K | 0.23% | 109 |
|
|
2018
Q1 | $7.43M | Sell |
33,827
-676
| -2% | -$159K | 0.23% | 104 |
|
|
2017
Q4 | $7.76M | Buy |
+34,503
| New | +$7.35M | 0.24% | 107 |
|
Other funds holding ELV
VCM
VPM
Nissay Asset Management's ELV Position: Q1 2026 in Review
Nissay Asset Management increased its Elevance Health (ELV) stake by 0.1% in Q1 2026, buying an estimated $9.53K and bringing the position to 28,825 shares worth $8.44M. The position accounts for 0.04% of the portfolio, ranked #244.
Nissay Asset Management first reported a position in ELV in Q4 2017 and has held it in 34 quarters since. The position peaked at $15.3M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Nissay Asset Management held 28,825 shares of Elevance Health worth $8.44M as of Q1 2026.
- Nissay Asset Management bought 29 Elevance Health shares in Q1 2026, an estimated $9.53K.
- Elevance Health made up 0.04% of Nissay Asset Management's portfolio in Q1 2026, its #244 holding.
- Nissay Asset Management first reported a position in Elevance Health in Q4 2017 and has held it in 34 quarters since.
- Nissay Asset Management's Elevance Health position peaked at $15.3M in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Nissay Asset Management's 13F filing for Q1 2026, filed 15 May 2026.